EBR Systems raises $20 million to propel development and regulatory approval of its wireless cardiac resynchronization therapy device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DQMzJl
Cap comentari:
Publica un comentari a l'entrada